You have requested access to member-only content.

CMS considers eliminating inpatient-only list, expanding prior authorization

CMS continues to focus on site-neutral payment policies and keeping payments down for 340B-acquired drugs in the 2021 OPPS proposed rule, released in early August.

This is an excerpt from member-only content. Please log in or become a member.

Not a member? Join now!

Revenue Cycle Advisor is the key to your organization's Medicare regulatory news and education. It combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule updates thoroughly.

For questions and support, please call customer service: 800-650-6787.